IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms11375.html
   My bibliography  Save this article

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

Author

Listed:
  • Fergus J. Couch

    (Mayo Clinic
    Mayo Clinic)

  • Karoline B. Kuchenbaecker

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Kyriaki Michailidou

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Gustavo A. Mendoza-Fandino

    (Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute)

  • Silje Nord

    (Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet)

  • Janna Lilyquist

    (Mayo Clinic)

  • Curtis Olswold

    (Mayo Clinic)

  • Emily Hallberg

    (Mayo Clinic)

  • Simona Agata

    (Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV—IRCCS)

  • Habibul Ahsan

    (The University of Chicago
    Comprehensive Cancer Center, The University of Chicago
    The University of Chicago)

  • Kristiina Aittomäki

    (Helsinki University Central Hospital)

  • Christine Ambrosone

    (Roswell Park Cancer Institute)

  • Irene L. Andrulis

    (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
    University of Toronto)

  • Hoda Anton-Culver

    (University of California Irvine)

  • Volker Arndt

    (German Cancer Research Center (DKFZ))

  • Banu K. Arun

    (University of Texas MD Anderson Cancer Center)

  • Brita Arver

    (Karolinska University Hospital)

  • Monica Barile

    (Istituto Europeo di Oncologia)

  • Rosa B. Barkardottir

    (Landspitali University Hospital and University of Iceland School of Medicine)

  • Daniel Barrowdale

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Lars Beckmann

    (Institute for Quality and Efficiency in Health Care (IQWiG))

  • Matthias W. Beckmann

    (University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN)

  • Javier Benitez

    (Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO)
    Genotyping Unit (CeGen), Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO)
    Biomedical Network on Rare Diseases (CIBERER))

  • Stephanie V. Blank

    (NYU Women’s Cancer Program, New York University School of Medicine)

  • Carl Blomqvist

    (University of Helsinki and Helsinki University Central Hospital)

  • Natalia V. Bogdanova

    (Hannover Medical School)

  • Stig E. Bojesen

    (Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital)

  • Manjeet K. Bolla

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Bernardo Bonanni

    (Istituto Europeo di Oncologia)

  • Hiltrud Brauch

    (Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology
    University of Tübingen)

  • Hermann Brenner

    (German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT))

  • Barbara Burwinkel

    (University of Heidelberg)

  • Saundra S. Buys

    (Huntsman Cancer Institute, University of Utah School of Medicine)

  • Trinidad Caldes

    (Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC)

  • Maria A. Caligo

    (Section of Genetic Oncology, University and University Hospital of Pisa)

  • Federico Canzian

    (Genomic Epidemiology Group, German Cancer Research Center (DKFZ))

  • Jane Carpenter

    (Australian Breast Cancer Tissue Bank, Westmead Millennium Institute, University of Sydney)

  • Jenny Chang-Claude

    (German Cancer Research Center (DKFZ))

  • Stephen J. Chanock

    (National Cancer Institute)

  • Wendy K. Chung

    (Columbia University)

  • Kathleen B. M. Claes

    (Center for Medical Genetics, Ghent University)

  • Angela Cox

    (Sheffield Cancer Research Centre, University of Sheffield)

  • Simon S. Cross

    (Academic Unit of Pathology, University of Sheffield)

  • Julie M. Cunningham

    (Mayo Clinic)

  • Kamila Czene

    (Karolinska Institutet)

  • Mary B. Daly

    (Fox Chase Cancer Center)

  • Francesca Damiola

    (INSERM U1052, CNRS UMR5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon)

  • Hatef Darabi

    (Karolinska Institutet)

  • Miguel de la Hoya

    (Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC)

  • Peter Devilee

    (Leiden University Medical Center)

  • Orland Diez

    (Oncogenetics Group, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO) and Universitat Autònoma de Barcelona)

  • Yuan C. Ding

    (Beckman Research Institute of City of Hope)

  • Riccardo Dolcetti

    (Cancer Bioimmunotherapy Unit, CRO Aviano National Cancer Institute)

  • Susan M. Domchek

    (Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania)

  • Cecilia M. Dorfling

    (University of Pretoria)

  • Isabel dos-Santos-Silva

    (London School of Hygiene and Tropical Medicine)

  • Martine Dumont

    (Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec and Laval University)

  • Alison M. Dunning

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Diana M. Eccles

    (Faculty of Medicine, University of Southampton, University Hospital Southampton)

  • Hans Ehrencrona

    (Genetics and Pathology, Uppsala University
    Lund University Hospital)

  • Arif B. Ekici

    (Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg
    Comprehensive Cancer Center -EMN)

  • Heather Eliassen

    (Brigham and Women's Hospital and Harvard Medical School
    Harvard School of Public Health)

  • Steve Ellis

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Peter A. Fasching

    (University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN)

  • Jonine Figueroa

    (National Cancer Institute)

  • Dieter Flesch-Janys

    (University Clinic Hamburg-Eppendorf)

  • Asta Försti

    (German Cancer Research Center (DKFZ)
    Center for Primary Health Care Research, Lund University)

  • Florentia Fostira

    (Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research ‘Demokritos’, Aghia Paraskevi Attikis)

  • William D. Foulkes

    (Program in Cancer Genetics, McGill University)

  • Tara Friebel

    (University of)

  • Eitan Friedman

    (Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center)

  • Debra Frost

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Marike Gabrielson

    (Karolinska Institutet)

  • Marilie D. Gammon

    (University of)

  • Patricia A. Ganz

    (UCLA Schools of Medicine and Public Health, Jonsson Comprehensive Cancer Center)

  • Susan M. Gapstur

    (Epidemiology Research Program, American Cancer Society)

  • Judy Garber

    (Cancer Risk and Prevention Clinic, Dana Farber Cancer Institute)

  • Mia M. Gaudet

    (Epidemiology Research Program, American Cancer Society)

  • Simon A. Gayther

    (Cedars Sinai Medical Center)

  • Anne-Marie Gerdes

    (Rigshospitalet, Copenhagen University Hospital)

  • Maya Ghoussaini

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Graham G. Giles

    (Cancer Epidemiology Centre, Cancer Council Victoria)

  • Gord Glendon

    (Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital)

  • Andrew K. Godwin

    (University of Kansas Medical Center)

  • Mark S. Goldberg

    (McGill University
    McGill University Health Centre, Royal Victoria Hospital)

  • David E. Goldgar

    (Huntsman Cancer Institute, University of Utah School of Medicine)

  • Anna González-Neira

    (Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO))

  • Mark H. Greene

    (Clinical Genetics Branch, National Cancer Institute, National Institutes of Health)

  • Jacek Gronwald

    (Pomeranian Medical University)

  • Pascal Guénel

    (Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer)

  • Marc Gunter

    (School of Public Health, Imperial College London)

  • Lothar Haeberle

    (University Breast Center Franconia, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN)

  • Christopher A. Haiman

    (Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center)

  • Ute Hamann

    (Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ))

  • Thomas V. O. Hansen

    (Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital)

  • Steven Hart

    (Mayo Clinic)

  • Sue Healey

    (QIMR Berghofer Medical Research Institute)

  • Tuomas Heikkinen

    (University of Heidelberg
    Helsinki University Central Hospital)

  • Brian E. Henderson

    (Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center)

  • Josef Herzog

    (Clinical Cancer Genetics, for the City of Hope Clinical Cancer Genetics Community Research Network)

  • Frans B. L. Hogervorst

    (Family Cancer Clinic, Netherlands Cancer Institute)

  • Antoinette Hollestelle

    (Erasmus MC Cancer Institute)

  • Maartje J. Hooning

    (Family Cancer Clinic, Erasmus University Medical Center)

  • Robert N. Hoover

    (National Cancer Institute)

  • John L. Hopper

    (Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne)

  • Keith Humphreys

    (Karolinska Institutet)

  • David J. Hunter

    (Program in Molecular and Genetic Epidemiology, Harvard School of Public Health)

  • Tomasz Huzarski

    (Pomeranian Medical University)

  • Evgeny N. Imyanitov

    (N.N. Petrov Institute of Oncology)

  • Claudine Isaacs

    (Lombardi Comprehensive Cancer Center, Georgetown University)

  • Anna Jakubowska

    (Pomeranian Medical University)

  • Paul James

    (Familial Cancer Centre, Peter MacCallum Cancer Centre
    The University of Melbourne)

  • Ramunas Janavicius

    (State Research Institute Centre for Innovative Medicine)

  • Uffe Birk Jensen

    (Aarhus University Hospital)

  • Esther M. John

    (Cancer Prevention Institute of California)

  • Michael Jones

    (Institute of Cancer Research)

  • Maria Kabisch

    (Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ))

  • Siddhartha Kar

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Beth Y. Karlan

    (Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center)

  • Sofia Khan

    (University of Helsinki and Helsinki University Central Hospital)

  • Kay-Tee Khaw

    (University of Cambridge, Strangeways Research Laboratory)

  • Muhammad G. Kibriya

    (The University of Chicago)

  • Julia A. Knight

    (Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital)

  • Yon-Dschun Ko

    (Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus)

  • Irene Konstantopoulou

    (Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research ‘Demokritos’, Aghia Paraskevi Attikis)

  • Veli-Matti Kosma

    (School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland)

  • Vessela Kristensen

    (Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet)

  • Ava Kwong

    (The Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Center, Hong Kong Sanatorium and Hospital
    The University of Hong Kong)

  • Yael Laitman

    (Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center)

  • Diether Lambrechts

    (Vesalius Research Center, VIB)

  • Conxi Lazaro

    (Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology)

  • Eunjung Lee

    (University of Southern California)

  • Loic Le Marchand

    (Cancer Epidemiology Program, University of Cancer Center)

  • Jenny Lester

    (Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center)

  • Annika Lindblom

    (Karolinska Institutet)

  • Noralane Lindor

    (Health Sciences Research, Mayo Clinic)

  • Sara Lindstrom

    (Harvard School of Public Health
    Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health)

  • Jianjun Liu

    (Genome Institute of Singapore)

  • Jirong Long

    (Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine)

  • Jan Lubinski

    (Pomeranian Medical University)

  • Phuong L. Mai

    (Clinical Genetics Branch, National Cancer Institute, National Institutes of Health)

  • Enes Makalic

    (Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne)

  • Kathleen E. Malone

    (Fred Hutchinson Cancer Research Center
    School of Public Health and Community Medicine, University of Washington)

  • Arto Mannermaa

    (School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland)

  • Siranoush Manoukian

    (Unit of Medical Genetics, Fondazione IRCCS Istituto Nazionale Tumori (INT))

  • Sara Margolin

    (Karolinska University Hospital)

  • Frederik Marme

    (University of Heidelberg)

  • John W. M. Martens

    (Erasmus MC Cancer Institute)

  • Lesley McGuffog

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Alfons Meindl

    (Technical University of Munich)

  • Austin Miller

    (NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute)

  • Roger L. Milne

    (Cancer Epidemiology Centre, Cancer Council Victoria)

  • Penelope Miron

    (Case Western Reserve University Medical School)

  • Marco Montagna

    (Immunology and Molecular Oncology Unit, Istituto Oncologico Veneto IOV—IRCCS)

  • Sylvie Mazoyer

    (INSERM U1052, CNRS UMR5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon)

  • Anna M. Mulligan

    (Laboratory Medicine Program, University Health Network
    University of Toronto)

  • Taru A. Muranen

    (University of Heidelberg
    Helsinki University Central Hospital)

  • Katherine L. Nathanson

    (Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania)

  • Susan L. Neuhausen

    (Beckman Research Institute of City of Hope)

  • Heli Nevanlinna

    (University of Helsinki and Helsinki University Central Hospital)

  • Børge G. Nordestgaard

    (Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital)

  • Robert L. Nussbaum

    (Invitae Corporation)

  • Kenneth Offit

    (Memorial Sloan-Kettering Cancer Center)

  • Edith Olah

    (National Institute of Oncology)

  • Olufunmilayo I. Olopade

    (Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center)

  • Janet E. Olson

    (Mayo Clinic)

  • Ana Osorio

    (Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Centre (CNIO))

  • Sue K. Park

    (Seoul National University College of Medicine and Cancer Research Institute, Seoul National University)

  • Petra H. Peeters

    (Julius Center for Health Sciences and Primary Care, University Medical Center
    MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London)

  • Bernard Peissel

    (Unit of Medical Genetics, Fondazione IRCCS Istituto Nazionale Tumori (INT))

  • Paolo Peterlongo

    (IFOM, Fondazione Istituto FIRC di Oncologia Molecolare)

  • Julian Peto

    (London School of Hygiene and Tropical Medicine)

  • Catherine M. Phelan

    (Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute)

  • Robert Pilarski

    (Divison of Human Genetics, The Comprehensive Cancer Center, The Ohio State University)

  • Bruce Poppe

    (Center for Medical Genetics, Ghent University)

  • Katri Pylkäs

    (Laboratory of Cancer Genetics and Tumor Biology, University of Oulu, NordLab Oulu/Oulu University Hospital)

  • Paolo Radice

    (Unit of Molecular Bases of Genetic Risk and Genetic Testing, Fondazione IRCCS Istituto Nazionale Tumori (INT))

  • Nazneen Rahman

    (Section of Cancer Genetics, Institute of Cancer Research)

  • Johanna Rantala

    (Karolinska University Hospital)

  • Christine Rappaport

    (Comprehensive Cancer Center, Medical University of Vienna)

  • Gad Rennert

    (Carmel Medical Center and B. Rappaport Faculty of Medicine)

  • Andrea Richardson

    (Johns Hopkins University School of Medicine)

  • Mark Robson

    (Memorial Sloan-Kettering Cancer Center)

  • Isabelle Romieu

    (International Agency for Research on Cancer)

  • Anja Rudolph

    (German Cancer Research Center (DKFZ))

  • Emiel J. Rutgers

    (Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital)

  • Maria-Jose Sanchez

    (Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada
    CIBER de Epidemiología y Salud Pública (CIBERESP))

  • Regina M. Santella

    (Columbia University)

  • Elinor J. Sawyer

    (Research Oncology, King's College London, Guy’s Hospital)

  • Daniel F. Schmidt

    (Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne)

  • Marjanka K. Schmidt

    (Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital)

  • Rita K. Schmutzler

    (Center for Hereditary Breast and Ovarian Cancer, Medical Faculty, University Hospital Cologne
    Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne
    Center for Molecular Medicine Cologne (CMMC), University of Cologne)

  • Fredrick Schumacher

    (Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center)

  • Rodney Scott

    (Hunter Area Pathology Service, John Hunter Hospital)

  • Leigha Senter

    (Divison of Human Genetics, The Comprehensive Cancer Center, The Ohio State University)

  • Priyanka Sharma

    (University of Kansas Medical Center)

  • Jacques Simard

    (Centre Hospitalier Universitaire de Québec Research Center, Laval University)

  • Christian F. Singer

    (Comprehensive Cancer Center, Medical University of Vienna)

  • Olga M. Sinilnikova

    (INSERM U1052, CNRS UMR5286, Université Lyon, Centre de Recherche en Cancérologie de Lyon
    Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon—Centre Léon Bérard)

  • Penny Soucy

    (Centre Hospitalier Universitaire de Québec Research Center, Laval University)

  • Melissa Southey

    (The University of Melbourne)

  • Doris Steinemann

    (Hannover Medical School)

  • Marie Stenmark-Askmalm

    (Linköping University)

  • Dominique Stoppa-Lyonnet

    (Institut Curie
    Université Paris Descartes, Sorbonne Paris Cité)

  • Anthony Swerdlow

    (Institute of Cancer Research)

  • Csilla I. Szabo

    (National Human Genome Research Institute, National Institutes of Health)

  • Rulla Tamimi

    (Brigham and Women's Hospital and Harvard Medical School
    Harvard School of Public Health
    Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health)

  • William Tapper

    (Faculty of Medicine, University of Southampton, University Hospital Southampton)

  • Manuel R. Teixeira

    (Portuguese Oncology Institute
    Biomedical Sciences Institute (ICBAS), Porto University)

  • Soo-Hwang Teo

    (Cancer Research Initiatives Foundation, Sime Darby Medical Centre
    University Malaya Cancer Research Institute, Faculty of Medicine, University Malaya Medical Centre, University Malaya)

  • Mary B. Terry

    (Mailman School of Public Health, Columbia University)

  • Mads Thomassen

    (Odense University Hospital)

  • Deborah Thompson

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Laima Tihomirova

    (Latvian Biomedical Research and Study Centre)

  • Amanda E. Toland

    (Immunology and Medical Genetics, The Ohio State University)

  • Robert A. E. M. Tollenaar

    (Leiden University Medical Center)

  • Ian Tomlinson

    (Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford)

  • Thérèse Truong

    (Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer)

  • Helen Tsimiklis

    (The University of Melbourne)

  • Alex Teulé

    (Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology)

  • Rosario Tumino

    (Cancer Registry and Histopathology Unit, ‘Civic—M.P. Arezzo’ Hospital)

  • Nadine Tung

    (Beth Israel Deaconess Medical Center)

  • Clare Turnbull

    (Section of Cancer Genetics, Institute of Cancer Research)

  • Giski Ursin

    (Cancer Registry of Norway, Institute of Population-Based Cancer Research)

  • Carolien H. M. van Deurzen

    (Family Cancer Clinic, Erasmus University Medical Center)

  • Elizabeth J. van Rensburg

    (University of Pretoria)

  • Raymonda Varon-Mateeva

    (Institute of Human Genetics, Charite Berlin)

  • Zhaoming Wang

    (Cancer Genomics Research Laboratory, National Cancer Institute)

  • Shan Wang-Gohrke

    (University Hospital Ulm)

  • Elisabete Weiderpass

    (Karolinska Institutet
    Cancer Registry of Norway, Institute of Population-Based Cancer Research
    Faculty of Health Sciences, University of Tromsø—The Arctic University of Norway
    Genetic Epidemiology Group, Folkhälsan Research Center)

  • Jeffrey N. Weitzel

    (Clinical Cancer Genetics, for the City of Hope Clinical Cancer Genetics Community Research Network)

  • Alice Whittemore

    (Stanford University School of Medicine)

  • Hans Wildiers

    (Multidisciplinary Breast Center, University Hospitals)

  • Robert Winqvist

    (Laboratory of Cancer Genetics and Tumor Biology, University of Oulu, NordLab Oulu/Oulu University Hospital)

  • Xiaohong R. Yang

    (National Cancer Institute)

  • Drakoulis Yannoukakos

    (Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research ‘Demokritos’, Aghia Paraskevi Attikis)

  • Song Yao

    (Roswell Park Cancer Institute)

  • M Pilar Zamora

    (Servicio de Oncología Médica, Hospital Universitario La Paz)

  • Wei Zheng

    (Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine)

  • Per Hall

    (Karolinska Institutet)

  • Peter Kraft

    (Harvard School of Public Health
    Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health
    Harvard School Of Public Health)

  • Celine Vachon

    (Mayo Clinic)

  • Susan Slager

    (Mayo Clinic)

  • Georgia Chenevix-Trench

    (QIMR Berghofer Medical Research Institute)

  • Paul D. P. Pharoah

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Alvaro A. N. Monteiro

    (Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute)

  • Montserrat García-Closas

    (National Cancer Institute, National Institutes of Health)

  • Douglas F. Easton

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

  • Antonis C. Antoniou

    (Centre for Cancer Genetic Epidemiology, University of Cambridge)

Abstract

Common variants in 94 loci have been associated with breast cancer including 15 loci with genome-wide significant associations (P

Suggested Citation

  • Fergus J. Couch & Karoline B. Kuchenbaecker & Kyriaki Michailidou & Gustavo A. Mendoza-Fandino & Silje Nord & Janna Lilyquist & Curtis Olswold & Emily Hallberg & Simona Agata & Habibul Ahsan & Kristii, 2016. "Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer," Nature Communications, Nature, vol. 7(1), pages 1-13, September.
    • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11375
    DOI: 10.1038/ncomms11375
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms11375
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms11375?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11375. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.